These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25980428)
1. Cost-effectiveness of norovirus vaccination in children in Peru. Mirelman AJ; Ballard SB; Saito M; Kosek MN; Gilman RH Vaccine; 2015 Jun; 33(27):3084-91. PubMed ID: 25980428 [TBL] [Abstract][Full Text] [Related]
2. The potential economic value of a human norovirus vaccine for the United States. Bartsch SM; Lopman BA; Hall AJ; Parashar UD; Lee BY Vaccine; 2012 Nov; 30(49):7097-104. PubMed ID: 23026689 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model. Patel HD; Roberts ET; Constenla DO Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497 [TBL] [Abstract][Full Text] [Related]
4. Epidemiologic challenges in norovirus vaccine development. Hallowell BD; Parashar UD; Hall AJ Hum Vaccin Immunother; 2019; 15(6):1279-1283. PubMed ID: 30481104 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ; Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study. Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana. Abbott C; Tiede B; Armah G; Mahmoud A Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of rotavirus vaccination in Albania. Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study. Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of rotavirus vaccination in Argentina. Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Tucker AW; Haddix AC; Bresee JS; Holman RC; Parashar UD; Glass RI JAMA; 1998 May; 279(17):1371-6. PubMed ID: 9582045 [TBL] [Abstract][Full Text] [Related]
14. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Milne RJ; Grimwood K Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550 [TBL] [Abstract][Full Text] [Related]
15. Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country setting. Ballard SB; Tallant A; Guerra RG; Quigley D; Stiegmann R; Mirelman AJ; Riddle MS; Gilman RH; Vaccine; 2020 Feb; 38(10):2292-2297. PubMed ID: 32019702 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of rotavirus vaccination in Mozambique. Lourenço Guimarães E; Chissaque A; Pecenka C; Clark A; Vaz B; Banze A; Canana N; Romão C; do Rosário Oliveira Martins M; de Deus N; Debellut F Vaccine; 2022 Aug; 40(36):5338-5346. PubMed ID: 35933279 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rotavirus vaccination programs in Taiwan. Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569 [TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of pneumococcal conjugate vaccination in The Gambia. Kim SY; Lee G; Goldie SJ BMC Infect Dis; 2010 Sep; 10():260. PubMed ID: 20815900 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis. Janko MM; Joffe J; Michael D; Earl L; Rosettie KL; Sparks GW; Albertson SB; Compton K; Pedroza Velandia P; Stafford L; Zheng P; Aravkin A; Kyu HH; Murray CJL; Weaver MR Vaccine; 2022 Jun; 40(28):3903-3917. PubMed ID: 35643565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]